Researchers (IMAGE)
Caption
Gerald Dorn, PhD, (left) and staff scientist Agostinho Rocha, PhD, study mitochondria in relation to Charcot-Marie-Tooth disease in Dorn's lab. The researchers, from Washington University School of Medicine in St. Louis, have developed a drug compound that shows promise as a future treatment for this disease.
Credit
Matt Miller
Usage Restrictions
None
License
Licensed content